aluates Reports

$ 0.0

Automative

Global Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Market Insights, Forecast to 2030

Published Date: December 2024

Report Code: QYRE-Auto-20D9534

Global Leber s Hereditary Optic Neuropathy LHON Leber Optic Atrophy Market Insights Forecast to 2028

BUY CHAPTERS

Global Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Market Insights, Forecast to 2030

Code: QYRE-Auto-20D9534

Report

December 2024

Pages:111

QYResearch

Buy Now with 15% Discount

DESCRIPTION

TABLE OF CONTENT

TABLES & FIGURES

FEATURED COMPANIES

Alkeus Pharmaceuticals

Amgen Inc

Biovista Inc

Editas Medicine

GenSight Biologics

Ixchel Pharma

Khondrion BV

Mitotech S.A.

ProQR Therapeutics

Sanofi

Spark Therapeutics

Stealth Biotherapeutics

Usher Syndrome

Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Market

Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) is maternal inheritance, or mitochondrial inheritance, caused by mutations in mitochondrial DNA11778, 14484 or 3460.It's a common type of inherited optic neuropathy. Related drugs include oxygen, ribonucleic acid, arginine, aidibenzoquinone, vitamin C, unoprostol.

The global Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) market is projected to grow from US$ million in 2024 to US$ million by 2030, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.

The US & Canada market for Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.

The China market for Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.

The Europe market for Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.

The global key manufacturers of Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) include Alkeus Pharmaceuticals, Amgen, Biovista, Editas Medicine, GenSight Biologics, Ixchel Pharma, Khondrion, Mitotech and ProQR Therapeutics, etc. In 2023, the global top five players had a share approximately % in terms of revenue.

Report Covers:

This report presents an overview of global market for Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy), sales, revenue and price. Analyses of the global market trends, with historic market revenue/sales data for 2019 - 2023, estimates for 2024, and projections of CAGR through 2030.

This report researches the key producers of Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy), also provides the sales of main regions and countries. Highlights of the upcoming market potential for Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy), and key regions/countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) sales, revenue, market share and industry ranking of main manufacturers, data from 2019 to 2024. Identification of the major stakeholders in the global Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type, and by Application, sales, revenue, and price, from 2019 to 2030. Evaluation and forecast the market size for Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) sales, projected growth trends, production technology, application and end-user industry.

Market Segmentation

Scope of Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Market Report

Report Metric	Details
Report Name	Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Market
Segment by Type	Dominant Optic Atrophy Recessive Optic Atrophy
Segment by Application	Hospitals Eye Clinics Medical Research Institute Other
Segment by Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Rest of Europe Nordic Countries Asia-Pacific (China, Japan, South Korea) Southeast Asia (India, Australia) Rest of Asia Latin America (Mexico, Brazil) Rest of Latin America Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company	Biovista, Editas Medicine, GenSight Biologics, Ixchel Pharma, Khondrion, Mitotech, ProQR Therapeutics, Sanofi, Spark Therapeutics, Stealth BioTherapeutics, Usher Syndrome
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, and by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Sales (consumption), revenue of Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) in global, regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 3: Detailed analysis of Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: North America (US & Canada) by Type, by Application and by country, sales, and revenue for each segment.
Chapter 7: Europe by Type, by Application and by country, sales, and revenue for each segment.
Chapter 8: China by Type, and by Application, sales, and revenue for each segment.
Chapter 9: Asia (excluding China) by Type, by Application and by region, sales, and revenue for each segment.
Chapter 10: Middle East, Africa, and Latin America by Type, by Application and by country, sales, and revenue for each segment.
Chapter 11: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) sales, revenue, price, gross margin, and recent development, etc.
Chapter 12: Analysis of industrial chain, sales channel, key raw materials, distributors and customers.
Chapter 13: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 14: The main points and conclusions of the report.

FAQ for this report

Who are the main players in the Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Market report?

Ans: The main players in the Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Market are Biovista, Editas Medicine, GenSight Biologics, Ixchel Pharma, Khondrion, Mitotech, ProQR Therapeutics, Sanofi, Spark Therapeutics, Stealth BioTherapeutics, Usher Syndrome

What are the Application segmentation covered in the Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Market report?

Ans: The Applications covered in the Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Market report are Hospitals, Eye Clinics, Medical Research Institute, Other

What are the Type segmentation covered in the Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Market report?

Ans: The Types covered in the Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Market report are Dominant Optic Atrophy, Recessive Optic Atrophy

Recommended Reports

Optic and Retinal Disorders

Neuromuscular & Mitochondrial

Genetic & Rare Diseases

1 Study Coverage

1.1 Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Product Introduction

1.2 Market by Type

1.2.1 Global Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Market Size Growth Rate by Type, 2019 VS 2023 VS 2030

1.2.2 Dominant Optic Atrophy

1.2.3 Recessive Optic Atrophy

1.3 Market by Application

1.3.1 Global Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Market Size Growth Rate by Application, 2019 VS 2023 VS 2030

1.3.2 Hospitals

1.3.3 Eye Clinics

1.3.4 Medical Research Institute

1.3.5 Other

1.4 Assumptions and Limitations

1.5 Study Objectives

1.6 Years Considered

2 Executive Summary

2.1 Global Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Sales Estimates and Forecasts 2019-2030

2.2 Global Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Revenue by Region

2.2.1 Global Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Revenue by Region: 2019 VS 2023 VS 2030

2.2.2 Global Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Revenue by Region (2019-2024)

2.2.3 Global Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Revenue by Region (2025-2030)

2.2.4 Global Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Revenue Market Share by Region (2019-2030)

2.3 Global Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Sales Estimates and Forecasts 2019-2030

2.4 Global Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Sales by Region

2.4.1 Global Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Sales by Region: 2019 VS 2023 VS 2030

2.4.2 Global Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Sales by Region (2019-2024)

2.4.3 Global Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Sales by Region (2025-2030)

2.4.4 Global Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Sales Market Share by Region (2019-2030)

2.5 US & Canada

2.6 Europe

2.7 China

2.8 Asia (excluding China)

2.9 Middle East, Africa and Latin America

3 Competition by Manufactures

3.1 Global Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Sales by Manufacturers

3.1.1 Global Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Sales by Manufacturers (2019-2024)

3.1.2 Global Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Sales Market Share by Manufacturers (2019-2024)

3.1.3 Global Top 10 and Top 5 Largest Manufacturers of Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) in 2023

3.2 Global Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Revenue by Manufacturers

3.2.1 Global Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Revenue by Manufacturers (2019-2024)

3.2.2 Global Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Revenue Market Share by Manufacturers (2019-2024)

3.2.3 Global Top 10 and Top 5 Companies by Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Revenue in 2023

3.3 Global Key Players of Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy), Industry Ranking, 2022 VS 2023 VS 2024

3.4 Global Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Sales Price by Manufacturers

3.5 Analysis of Competitive Landscape

3.5.1 Manufacturers Market Concentration Ratio (CR5 and HHI)

3.5.2 Global Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

3.6 Global Key Manufacturers of Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy), Manufacturing Base Distribution and Headquarters

3.7 Global Key Manufacturers of Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy), Product Offered and Application

3.8 Global Key Manufacturers of Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy), Date of Enter into This Industry

3.9 Mergers & Acquisitions, Expansion Plans

4 Market Size by Type

4.1 Global Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Sales by Type

4.1.1 Global Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Historical Sales by Type (2019-2024)

4.1.2 Global Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Forecasted Sales by Type (2025-2030)

4.1.3 Global Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Sales Market Share by Type (2019-2030)

4.2 Global Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Revenue by Type

4.2.1 Global Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Historical Revenue by Type (2019-2024)

4.2.2 Global Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Forecasted Revenue by Type (2025-2030)

4.2.3 Global Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Revenue Market Share by Type (2019-2030)

4.3 Global Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Price by Type

4.3.1 Global Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Price by Type (2019-2024)

4.3.2 Global Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Price Forecast by Type (2025-2030)

5 Market Size by Application

5.1 Global Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Sales by Application

5.1.1 Global Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Historical Sales by Application (2019-2024)

5.1.2 Global Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Forecasted Sales by Application (2025-2030)

5.1.3 Global Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Sales Market Share by Application (2019-2030)

5.2 Global Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Revenue by Application

5.2.1 Global Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Historical Revenue by Application (2019-2024)

5.2.2 Global Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Forecasted Revenue by Application (2025-2030)

5.2.3 Global Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Revenue Market Share by Application (2019-2030)

5.3 Global Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Price by Application

5.3.1 Global Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Price by Application (2019-2024)

5.3.2 Global Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Price Forecast by Application (2025-2030)

6 US & Canada

6.1 US & Canada Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Market Size by Type

6.1.1 US & Canada Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Sales by Type (2019-2030)

6.1.2 US & Canada Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Revenue by Type (2019-2030)

6.2 US & Canada Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Market Size by Application

6.2.1 US & Canada Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Sales by Application (2019-2030)

6.2.2 US & Canada Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Revenue by Application (2019-2030)

6.3 US & Canada Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Market Size by Country

6.3.1 US & Canada Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Revenue by Country: 2019 VS 2023 VS 2030

6.3.2 US & Canada Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Sales by Country (2019-2030)

6.3.3 US & Canada Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Revenue by Country (2019-2030)

6.3.4 US

6.3.5 Canada

7 Europe

7.1 Europe Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Market Size by Type

7.1.1 Europe Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Sales by Type (2019-2030)

7.1.2 Europe Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Revenue by Type (2019-2030)

7.2 Europe Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Market Size by Application

7.2.1 Europe Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Sales by Application (2019-2030)

7.2.2 Europe Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Revenue by Application (2019-2030)

7.3 Europe Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Market Size by Country

7.3.1 Europe Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Revenue by Country: 2019 VS 2023 VS 2030

7.3.2 Europe Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Sales by Country (2019-2030)

7.3.3 Europe Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Revenue by Country (2019-2030)

7.3.4 Germany

7.3.5 France

7.3.6 U.K.

7.3.7 Italy

7.3.8 Russia

8 China

8.1 China Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Market Size

8.1.1 China Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Sales (2019-2030)

8.1.2 China Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Revenue (2019-2030)

8.2 China Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Market Size by Application

8.2.1 China Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Sales by Application (2019-2030)

8.2.2 China Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Revenue by Application (2019-2030)

9 Asia (excluding China)

9.1 Asia Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Market Size by Type

9.1.1 Asia Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Sales by Type (2019-2030)

9.1.2 Asia Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Revenue by Type (2019-2030)

9.2 Asia Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Market Size by Application

9.2.1 Asia Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Sales by Application (2019-2030)

9.2.2 Asia Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Revenue by Application (2019-2030)

9.3 Asia Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Sales by Region

9.3.1 Asia Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Revenue by Region: 2019 VS 2023 VS 2030

9.3.2 Asia Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Revenue by Region (2019-2030)

9.3.3 Asia Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Sales by Region (2019-2030)

9.3.4 Japan

9.3.5 South Korea

9.3.6 China Taiwan

9.3.7 Southeast Asia

9.3.8 India

10 Middle East, Africa and Latin America

10.1 Middle East, Africa and Latin America Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Market Size by Type

10.1.1 Middle East, Africa and Latin America Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Sales by Type (2019-2030)

10.1.2 Middle East, Africa and Latin America Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Revenue by Type (2019-2030)

10.2 Middle East, Africa and Latin America Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Market Size by Application

10.2.1 Middle East, Africa and Latin America Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Sales by Application (2019-2030)

10.2.2 Middle East, Africa and Latin America Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Revenue by Application (2019-2030)

10.3 Middle East, Africa and Latin America Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Sales by Country

10.3.1 Middle East, Africa and Latin America Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Revenue by Country: 2019 VS 2023 VS 2030

10.3.2 Middle East, Africa and Latin America Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Revenue by Country (2019-2030)

10.3.3 Middle East, Africa and Latin America Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Sales by Country (2019-2030)

10.3.4 Brazil

10.3.5 Mexico

10.3.6 Turkey

10.3.7 Israel

10.3.8 GCC Countries

11 Company Profiles

11.1 Alkeus Pharmaceuticals

11.1.1 Alkeus Pharmaceuticals Company Information

11.1.2 Alkeus Pharmaceuticals Overview

11.1.3 Alkeus Pharmaceuticals Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Sales, Price, Revenue and Gross Margin (2019-2024)

11.1.4 Alkeus Pharmaceuticals Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Product Model Numbers, Pictures, Descriptions and Specifications

11.1.5 Alkeus Pharmaceuticals Recent Developments

11.2 Amgen

11.2.1 Amgen Company Information

11.2.2 Amgen Overview

11.2.3 Amgen Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Sales, Price, Revenue and Gross Margin (2019-2024)

11.2.4 Amgen Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Product Model Numbers, Pictures, Descriptions and Specifications

11.2.5 Amgen Recent Developments

11.3 Biovista

11.3.1 Biovista Company Information

11.3.2 Biovista Overview

11.3.3 Biovista Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Sales, Price, Revenue and Gross Margin (2019-2024)

11.3.4 Biovista Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Product Model Numbers, Pictures, Descriptions and Specifications

11.3.5 Biovista Recent Developments

11.4 Editas Medicine

11.4.1 Editas Medicine Company Information

11.4.2 Editas Medicine Overview

11.4.3 Editas Medicine Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Sales, Price, Revenue and Gross Margin (2019-2024)

11.4.4 Editas Medicine Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Product Model Numbers, Pictures, Descriptions and Specifications

11.4.5 Editas Medicine Recent Developments

11.5 GenSight Biologics

11.5.1 GenSight Biologics Company Information

11.5.2 GenSight Biologics Overview

11.5.3 GenSight Biologics Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Sales, Price, Revenue and Gross Margin (2019-2024)

11.5.4 GenSight Biologics Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Product Model Numbers, Pictures, Descriptions and Specifications

11.5.5 GenSight Biologics Recent Developments

11.6 Ixchel Pharma

11.6.1 Ixchel Pharma Company Information

11.6.2 Ixchel Pharma Overview

11.6.3 Ixchel Pharma Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Sales, Price, Revenue and Gross Margin (2019-2024)

11.6.4 Ixchel Pharma Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Product Model Numbers, Pictures, Descriptions and Specifications

11.6.5 Ixchel Pharma Recent Developments

11.7 Khondrion

11.7.1 Khondrion Company Information

11.7.2 Khondrion Overview

11.7.3 Khondrion Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Sales, Price, Revenue and Gross Margin (2019-2024)

11.7.4 Khondrion Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Product Model Numbers, Pictures, Descriptions and Specifications

11.7.5 Khondrion Recent Developments

11.8 Mitotech

11.8.1 Mitotech Company Information

11.8.2 Mitotech Overview

11.8.3 Mitotech Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Sales, Price, Revenue and Gross Margin (2019-2024)

11.8.4 Mitotech Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Product Model Numbers, Pictures, Descriptions and Specifications

11.8.5 Mitotech Recent Developments

11.9 ProQR Therapeutics

11.9.1 ProQR Therapeutics Company Information

11.9.2 ProQR Therapeutics Overview

11.9.3 ProQR Therapeutics Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Sales, Price, Revenue and Gross Margin (2019-2024)

11.9.4 ProQR Therapeutics Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Product Model Numbers, Pictures, Descriptions and Specifications

11.9.5 ProQR Therapeutics Recent Developments

11.10 Sanofi

11.10.1 Sanofi Company Information

11.10.2 Sanofi Overview

11.10.3 Sanofi Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Sales, Price, Revenue and Gross Margin (2019-2024)

11.10.4 Sanofi Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Product Model Numbers, Pictures, Descriptions and Specifications

11.10.5 Sanofi Recent Developments

11.11 Spark Therapeutics

11.11.1 Spark Therapeutics Company Information

11.11.2 Spark Therapeutics Overview

11.11.3 Spark Therapeutics Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Sales, Price, Revenue and Gross Margin (2019-2024)

11.11.4 Spark Therapeutics Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Product Model Numbers, Pictures, Descriptions and Specifications

11.11.5 Spark Therapeutics Recent Developments

11.12 Stealth BioTherapeutics

11.12.1 Stealth BioTherapeutics Company Information

11.12.2 Stealth BioTherapeutics Overview

11.12.3 Stealth BioTherapeutics Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Sales, Price, Revenue and Gross Margin (2019-2024)

11.12.4 Stealth BioTherapeutics Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Product Model Numbers, Pictures, Descriptions and Specifications

11.12.5 Stealth BioTherapeutics Recent Developments

11.13 Usher Syndrome

11.13.1 Usher Syndrome Company Information

11.13.2 Usher Syndrome Overview

11.13.3 Usher Syndrome Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Sales, Price, Revenue and Gross Margin (2019-2024)

11.13.4 Usher Syndrome Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Product Model Numbers, Pictures, Descriptions and Specifications

11.13.5 Usher Syndrome Recent Developments

12 Industry Chain and Sales Channels Analysis

12.1 Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Industry Chain Analysis

12.2 Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Key Raw Materials

12.2.1 Key Raw Materials

12.2.2 Raw Materials Key Suppliers

12.3 Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Production Mode & Process

12.4 Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Sales and Marketing

12.4.1 Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Sales Channels

12.4.2 Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Distributors

12.5 Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Customers

13 Market Dynamics

13.1 Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Industry Trends

13.2 Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Market Drivers

13.3 Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Market Challenges

13.4 Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Market Restraints

14 Key Findings in The Global Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Study

15 Appendix

15.1 Research Methodology

15.1.1 Methodology/Research Approach

15.1.2 Data Source

15.2 Author Details

15.3 Disclaimer

FEATURED COMPANIES

Alkeus Pharmaceuticals

Amgen Inc

Biovista Inc

Editas Medicine

GenSight Biologics

Ixchel Pharma

Khondrion BV

Mitotech S.A.

ProQR Therapeutics

Sanofi

Spark Therapeutics

Stealth Biotherapeutics

Usher Syndrome

List of Tables

Table 1. Global Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Market Size Growth Rate by Type, 2019 VS 2023 VS 2030 (US$ Million)

Table 2. Major Manufacturers of Dominant Optic Atrophy

Table 3. Major Manufacturers of Recessive Optic Atrophy

Table 4. Global Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Market Size Growth Rate by Application, 2019 VS 2023 VS 2030 (US$ Million)

Table 5. Global Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Revenue Grow Rate (CAGR) by Region: 2019 VS 2023 VS 2030 (US$ Million)

Table 6. Global Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Revenue by Region (2019-2024) & (US$ Million)

Table 7. Global Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Revenue by Region (2025-2030) & (US$ Million)

Table 8. Global Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Revenue Market Share by Region (2019-2024)

Table 9. Global Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Revenue Market Share by Region (2025-2030)

Table 10. Global Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Sales Grow Rate (CAGR) by Region: 2019 VS 2023 VS 2030 (US$ Million)

Table 11. Global Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Sales by Region (2019-2024) & (K Pcs)

Table 12. Global Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Sales by Region (2025-2030) & (K Pcs)

Table 13. Global Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Sales Market Share by Region (2019-2024)

Table 14. Global Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Sales Market Share by Region (2025-2030)

Table 15. Global Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Sales by Manufacturers (2019-2024) & (K Pcs)

Table 16. Global Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Sales Share by Manufacturers (2019-2024)

Table 17. Global Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Revenue by Manufacturers (2019-2024) & (US$ Million)

Table 18. Global Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Revenue Share by Manufacturers (2019-2024)

Table 19. Global Key Players of Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy), Industry Ranking, 2022 VS 2023 VS 2024

Table 20. Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Price by Manufacturers 2019-2024 (USD/Piece)

Table 21. Global Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Manufacturers Market Concentration Ratio (CR5 and HHI)

Table 22. Global Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) as of 2023)

Table 23. Global Key Manufacturers of Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy), Manufacturing Base Distribution and Headquarters

Table 24. Global Key Manufacturers of Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy), Product Offered and Application

Table 25. Global Key Manufacturers of Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy), Date of Enter into This Industry

Table 26. Mergers & Acquisitions, Expansion Plans

Table 27. Global Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Sales by Type (2019-2024) & (K Pcs)

Table 28. Global Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Sales by Type (2025-2030) & (K Pcs)

Table 29. Global Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Sales Share by Type (2019-2024)

Table 30. Global Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Sales Share by Type (2025-2030)

Table 31. Global Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Revenue by Type (2019-2024) & (US$ Million)

Table 32. Global Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Revenue by Type (2025-2030) & (US$ Million)

Table 33. Global Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Revenue Share by Type (2019-2024)

Table 34. Global Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Revenue Share by Type (2025-2030)

Table 35. Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Price by Type (2019-2024) & (USD/Piece)

Table 36. Global Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Price Forecast by Type (2025-2030) & (USD/Piece)

Table 37. Global Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Sales by Application (2019-2024) & (K Pcs)

Table 38. Global Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Sales by Application (2025-2030) & (K Pcs)

Table 39. Global Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Sales Share by Application (2019-2024)

Table 40. Global Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Sales Share by Application (2025-2030)

Table 41. Global Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Revenue by Application (2019-2024) & (US$ Million)

Table 42. Global Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Revenue by Application (2025-2030) & (US$ Million)

Table 43. Global Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Revenue Share by Application (2019-2024)

Table 44. Global Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Revenue Share by Application (2025-2030)

Table 45. Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Price by Application (2019-2024) & (USD/Piece)

Table 46. Global Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Price Forecast by Application (2025-2030) & (USD/Piece)

Table 47. US & Canada Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Sales by Type (2019-2024) & (K Pcs)

Table 48. US & Canada Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Sales by Type (2025-2030) & (K Pcs)

Table 49. US & Canada Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Revenue by Type (2019-2024) & (US$ Million)

Table 50. US & Canada Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Revenue by Type (2025-2030) & (US$ Million)

Table 51. US & Canada Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Sales by Application (2019-2024) & (K Pcs)

Table 52. US & Canada Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Sales by Application (2025-2030) & (K Pcs)

Table 53. US & Canada Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Revenue by Application (2019-2024) & (US$ Million)

Table 54. US & Canada Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Revenue by Application (2025-2030) & (US$ Million)

Table 55. US & Canada Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Revenue Grow Rate (CAGR) by Country: 2019 VS 2023 VS 2030 (US$ Million)

Table 56. US & Canada Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Revenue by Country (2019-2024) & (US$ Million)

Table 57. US & Canada Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Revenue by Country (2025-2030) & (US$ Million)

Table 58. US & Canada Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Sales by Country (2019-2024) & (K Pcs)

Table 59. US & Canada Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Sales by Country (2025-2030) & (K Pcs)

Table 60. Europe Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Sales by Type (2019-2024) & (K Pcs)

Table 61. Europe Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Sales by Type (2025-2030) & (K Pcs)

Table 62. Europe Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Revenue by Type (2019-2024) & (US$ Million)

Table 63. Europe Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Revenue by Type (2025-2030) & (US$ Million)

Table 64. Europe Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Sales by Application (2019-2024) & (K Pcs)

Table 65. Europe Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Sales by Application (2025-2030) & (K Pcs)

Table 66. Europe Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Revenue by Application (2019-2024) & (US$ Million)

Table 67. Europe Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Revenue by Application (2025-2030) & (US$ Million)

Table 68. Europe Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Revenue Grow Rate (CAGR) by Country: 2019 VS 2023 VS 2030 (US$ Million)

Table 69. Europe Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Revenue by Country (2019-2024) & (US$ Million)

Table 70. Europe Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Revenue by Country (2025-2030) & (US$ Million)

Table 71. Europe Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Sales by Country (2019-2024) & (K Pcs)

Table 72. Europe Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Sales by Country (2025-2030) & (K Pcs)

Table 73. China Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Sales by Type (2019-2024) & (K Pcs)

Table 74. China Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Sales by Type (2025-2030) & (K Pcs)

Table 75. China Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Revenue by Type (2019-2024) & (US$ Million)

Table 76. China Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Revenue by Type (2025-2030) & (US$ Million)

Table 77. China Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Sales by Application (2019-2024) & (K Pcs)

Table 78. China Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Sales by Application (2025-2030) & (K Pcs)

Table 79. China Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Revenue by Application (2019-2024) & (US$ Million)

Table 80. China Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Revenue by Application (2025-2030) & (US$ Million)

Table 81. Asia Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Sales by Type (2019-2024) & (K Pcs)

Table 82. Asia Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Sales by Type (2025-2030) & (K Pcs)

Table 83. Asia Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Revenue by Type (2019-2024) & (US$ Million)

Table 84. Asia Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Revenue by Type (2025-2030) & (US$ Million)

Table 85. Asia Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Sales by Application (2019-2024) & (K Pcs)

Table 86. Asia Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Sales by Application (2025-2030) & (K Pcs)

Table 87. Asia Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Revenue by Application (2019-2024) & (US$ Million)

Table 88. Asia Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Revenue by Application (2025-2030) & (US$ Million)

Table 89. Asia Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Revenue Grow Rate (CAGR) by Country: 2019 VS 2023 VS 2030 (US$ Million)

Table 90. Asia Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Revenue by Region (2019-2024) & (US$ Million)

Table 91. Asia Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Revenue by Region (2025-2030) & (US$ Million)

Table 92. Asia Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Sales by Region (2019-2024) & (K Pcs)

Table 93. Asia Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Sales by Region (2025-2030) & (K Pcs)

Table 94. Middle East, Africa and Latin America Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Sales by Type (2019-2024) & (K Pcs)

Table 95. Middle East, Africa and Latin America Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Sales by Type (2025-2030) & (K Pcs)

Table 96. Middle East, Africa and Latin America Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Revenue by Type (2019-2024) & (US$ Million)

Table 97. Middle East, Africa and Latin America Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Revenue by Type (2025-2030) & (US$ Million)

Table 98. Middle East, Africa and Latin America Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Sales by Application (2019-2024) & (K Pcs)

Table 99. Middle East, Africa and Latin America Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Sales by Application (2025-2030) & (K Pcs)

Table 100. Middle East, Africa and Latin America Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Revenue by Application (2019-2024) & (US$ Million)

Table 101. Middle East, Africa and Latin America Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Revenue by Application (2025-2030) & (US$ Million)

Table 102. Middle East, Africa and Latin America Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Revenue Grow Rate (CAGR) by Country: 2019 VS 2023 VS 2030 (US$ Million)

Table 103. Middle East, Africa and Latin America Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Revenue by Country (2019-2024) & (US$ Million)

Table 104. Middle East, Africa and Latin America Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Revenue by Country (2025-2030) & (US$ Million)

Table 105. Middle East, Africa and Latin America Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Sales by Country (2019-2024) & (K Pcs)

Table 106. Middle East, Africa and Latin America Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Sales by Country (2025-2030) & (K Pcs)

Table 107. Alkeus Pharmaceuticals Company Information

Table 108. Alkeus Pharmaceuticals Description and Major Businesses

Table 109. Alkeus Pharmaceuticals Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Sales (K Pcs), Revenue (US$ Million), Price (USD/Piece) and Gross Margin (2019-2024)

Table 110. Alkeus Pharmaceuticals Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Product Model Numbers, Pictures, Descriptions and Specifications

Table 111. Alkeus Pharmaceuticals Recent Developments

Table 112. Amgen Company Information

Table 113. Amgen Description and Major Businesses

Table 114. Amgen Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Sales (K Pcs), Revenue (US$ Million), Price (USD/Piece) and Gross Margin (2019-2024)

Table 115. Amgen Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Product Model Numbers, Pictures, Descriptions and Specifications

Table 116. Amgen Recent Developments

Table 117. Biovista Company Information

Table 118. Biovista Description and Major Businesses

Table 119. Biovista Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Sales (K Pcs), Revenue (US$ Million), Price (USD/Piece) and Gross Margin (2019-2024)

Table 120. Biovista Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Product Model Numbers, Pictures, Descriptions and Specifications

Table 121. Biovista Recent Developments

Table 122. Editas Medicine Company Information

Table 123. Editas Medicine Description and Major Businesses

Table 124. Editas Medicine Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Sales (K Pcs), Revenue (US$ Million), Price (USD/Piece) and Gross Margin (2019-2024)

Table 125. Editas Medicine Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Product Model Numbers, Pictures, Descriptions and Specifications

Table 126. Editas Medicine Recent Developments

Table 127. GenSight Biologics Company Information

Table 128. GenSight Biologics Description and Major Businesses

Table 129. GenSight Biologics Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Sales (K Pcs), Revenue (US$ Million), Price (USD/Piece) and Gross Margin (2019-2024)

Table 130. GenSight Biologics Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Product Model Numbers, Pictures, Descriptions and Specifications

Table 131. GenSight Biologics Recent Developments

Table 132. Ixchel Pharma Company Information

Table 133. Ixchel Pharma Description and Major Businesses

Table 134. Ixchel Pharma Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Sales (K Pcs), Revenue (US$ Million), Price (USD/Piece) and Gross Margin (2019-2024)

Table 135. Ixchel Pharma Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Product Model Numbers, Pictures, Descriptions and Specifications

Table 136. Ixchel Pharma Recent Developments

Table 137. Khondrion Company Information

Table 138. Khondrion Description and Major Businesses

Table 139. Khondrion Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Sales (K Pcs), Revenue (US$ Million), Price (USD/Piece) and Gross Margin (2019-2024)

Table 140. Khondrion Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Product Model Numbers, Pictures, Descriptions and Specifications

Table 141. Khondrion Recent Developments

Table 142. Mitotech Company Information

Table 143. Mitotech Description and Major Businesses

Table 144. Mitotech Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Sales (K Pcs), Revenue (US$ Million), Price (USD/Piece) and Gross Margin (2019-2024)

Table 145. Mitotech Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Product Model Numbers, Pictures, Descriptions and Specifications

Table 146. Mitotech Recent Developments

Table 147. ProQR Therapeutics Company Information

Table 148. ProQR Therapeutics Description and Major Businesses

Table 149. ProQR Therapeutics Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Sales (K Pcs), Revenue (US$ Million), Price (USD/Piece) and Gross Margin (2019-2024)

Table 150. ProQR Therapeutics Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Product Model Numbers, Pictures, Descriptions and Specifications

Table 151. ProQR Therapeutics Recent Developments

Table 152. Sanofi Company Information

Table 153. Sanofi Description and Major Businesses

Table 154. Sanofi Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Sales (K Pcs), Revenue (US$ Million), Price (USD/Piece) and Gross Margin (2019-2024)

Table 155. Sanofi Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Product Model Numbers, Pictures, Descriptions and Specifications

Table 156. Sanofi Recent Developments

Table 157. Spark Therapeutics Company Information

Table 158. Spark Therapeutics Description and Major Businesses

Table 159. Spark Therapeutics Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Sales (K Pcs), Revenue (US$ Million), Price (USD/Piece) and Gross Margin (2019-2024)

Table 160. Spark Therapeutics Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Product Model Numbers, Pictures, Descriptions and Specifications

Table 161. Spark Therapeutics Recent Developments

Table 162. Stealth BioTherapeutics Company Information

Table 163. Stealth BioTherapeutics Description and Major Businesses

Table 164. Stealth BioTherapeutics Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Sales (K Pcs), Revenue (US$ Million), Price (USD/Piece) and Gross Margin (2019-2024)

Table 165. Stealth BioTherapeutics Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Product Model Numbers, Pictures, Descriptions and Specifications

Table 166. Stealth BioTherapeutics Recent Developments

Table 167. Usher Syndrome Company Information

Table 168. Usher Syndrome Description and Major Businesses

Table 169. Usher Syndrome Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Sales (K Pcs), Revenue (US$ Million), Price (USD/Piece) and Gross Margin (2019-2024)

Table 170. Usher Syndrome Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Product Model Numbers, Pictures, Descriptions and Specifications

Table 171. Usher Syndrome Recent Developments

Table 172. Key Raw Materials Lists

Table 173. Raw Materials Key Suppliers Lists

Table 174. Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Distributors List

Table 175. Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Customers List

Table 176. Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Market Trends

Table 177. Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Market Drivers

Table 178. Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Market Challenges

Table 179. Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Market Restraints

Table 180. Research Programs/Design for This Report

Table 181. Key Data Information from Secondary Sources

Table 182. Key Data Information from Primary Sources

List of Figures

Figure 1. Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Product Picture

Figure 2. Global Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Market Size Growth Rate by Type, 2019 VS 2023 VS 2030 (US$ Million)

Figure 3. Global Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Market Share by Type in 2023 & 2030

Figure 4. Dominant Optic Atrophy Product Picture

Figure 5. Recessive Optic Atrophy Product Picture

Figure 6. Global Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Market Size Growth Rate by Application, 2019 VS 2023 VS 2030 (US$ Million)

Figure 7. Global Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Market Share by Application in 2023 & 2030

Figure 8. Hospitals

Figure 9. Eye Clinics

Figure 10. Medical Research Institute

Figure 11. Other

Figure 12. Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Report Years Considered

Figure 13. Global Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Revenue, (US$ Million), 2019 VS 2023 VS 2030

Figure 14. Global Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Revenue 2019-2030 (US$ Million)

Figure 15. Global Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Revenue Market Share by Region in Percentage: 2023 Versus 2030

Figure 16. Global Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Revenue Market Share by Region (2019-2030)

Figure 17. Global Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Sales 2019-2030 ((K Pcs)

Figure 18. Global Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Sales Market Share by Region (2019-2030)

Figure 19. US & Canada Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Sales YoY (2019-2030) & (K Pcs)

Figure 20. US & Canada Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Revenue YoY (2019-2030) & (US$ Million)

Figure 21. Europe Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Sales YoY (2019-2030) & (K Pcs)

Figure 22. Europe Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Revenue YoY (2019-2030) & (US$ Million)

Figure 23. China Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Sales YoY (2019-2030) & (K Pcs)

Figure 24. China Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Revenue YoY (2019-2030) & (US$ Million)

Figure 25. Asia (excluding China) Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Sales YoY (2019-2030) & (K Pcs)

Figure 26. Asia (excluding China) Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Revenue YoY (2019-2030) & (US$ Million)

Figure 27. Middle East, Africa and Latin America Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Sales YoY (2019-2030) & (K Pcs)

Figure 28. Middle East, Africa and Latin America Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Revenue YoY (2019-2030) & (US$ Million)

Figure 29. The Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Market Share of Top 10 and Top 5 Largest Manufacturers Around the World in 2023

Figure 30. The Top 5 and 10 Largest Manufacturers of Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) in the World: Market Share by Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Revenue in 2023

Figure 31. Global Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2019 VS 2023

Figure 32. Global Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Sales Market Share by Type (2019-2030)

Figure 33. Global Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Revenue Market Share by Type (2019-2030)

Figure 34. Global Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Sales Market Share by Application (2019-2030)

Figure 35. Global Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Revenue Market Share by Application (2019-2030)

Figure 36. US & Canada Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Sales Market Share by Type (2019-2030)

Figure 37. US & Canada Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Revenue Market Share by Type (2019-2030)

Figure 38. US & Canada Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Sales Market Share by Application (2019-2030)

Figure 39. US & Canada Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Revenue Market Share by Application (2019-2030)

Figure 40. US & Canada Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Revenue Share by Country (2019-2030)

Figure 41. US & Canada Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Sales Share by Country (2019-2030)

Figure 42. U.S. Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Revenue (2019-2030) & (US$ Million)

Figure 43. Canada Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Revenue (2019-2030) & (US$ Million)

Figure 44. Europe Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Sales Market Share by Type (2019-2030)

Figure 45. Europe Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Revenue Market Share by Type (2019-2030)

Figure 46. Europe Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Sales Market Share by Application (2019-2030)

Figure 47. Europe Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Revenue Market Share by Application (2019-2030)

Figure 48. Europe Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Revenue Share by Country (2019-2030)

Figure 49. Europe Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Sales Share by Country (2019-2030)

Figure 50. Germany Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Revenue (2019-2030) & (US$ Million)

Figure 51. France Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Revenue (2019-2030) & (US$ Million)

Figure 52. U.K. Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Revenue (2019-2030) & (US$ Million)

Figure 53. Italy Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Revenue (2019-2030) & (US$ Million)

Figure 54. Russia Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Revenue (2019-2030) & (US$ Million)

Figure 55. China Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Sales Market Share by Type (2019-2030)

Figure 56. China Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Revenue Market Share by Type (2019-2030)

Figure 57. China Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Sales Market Share by Application (2019-2030)

Figure 58. China Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Revenue Market Share by Application (2019-2030)

Figure 59. Asia Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Sales Market Share by Type (2019-2030)

Figure 60. Asia Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Revenue Market Share by Type (2019-2030)

Figure 61. Asia Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Sales Market Share by Application (2019-2030)

Figure 62. Asia Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Revenue Market Share by Application (2019-2030)

Figure 63. Asia Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Revenue Share by Region (2019-2030)

Figure 64. Asia Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Sales Share by Region (2019-2030)

Figure 65. Japan Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Revenue (2019-2030) & (US$ Million)

Figure 66. South Korea Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Revenue (2019-2030) & (US$ Million)

Figure 67. China Taiwan Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Revenue (2019-2030) & (US$ Million)

Figure 68. Southeast Asia Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Revenue (2019-2030) & (US$ Million)

Figure 69. India Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Revenue (2019-2030) & (US$ Million)

Figure 70. Middle East, Africa and Latin America Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Sales Market Share by Type (2019-2030)

Figure 71. Middle East, Africa and Latin America Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Revenue Market Share by Type (2019-2030)

Figure 72. Middle East, Africa and Latin America Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Sales Market Share by Application (2019-2030)

Figure 73. Middle East, Africa and Latin America Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Revenue Market Share by Application (2019-2030)

Figure 74. Middle East, Africa and Latin America Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Revenue Share by Country (2019-2030)

Figure

SELECT A FORMAT

Added to Cart

Single User

Electronic (PDF)

$4900

This license allows only one user to access the PDF.

Multi User

Electronic (PDF)

$7350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Enterprise User